RJ

Ruby Jain

Active Director Director DIN 10242871
DIN 10242871 First appointment Jul 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jul 2023
Shareholding value Locked Premium profile

About Ruby Jain

Ruby Jain has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Ahinsa Medico Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10242871
Primary Designation Director
First Appointment 17 Jul 2023
Oldest Company Age 13 yrs

Current companies

Company Designation Appointment Founded Status
Ahinsa Medico Private Limited U51900DL2013PTC254416
Director 17 Jul 2023 2013 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ahinsa Medico Private Limited
Premium access

Shareholding and investment profile for Ruby Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ruby Jain

Ruby Jain has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Ahinsa Medico Private Limited. Engaged in General Business. Contributes to corporate operations.

Ruby Jain is associated with 1 company as Director.

Ruby Jain has expertise in General Business.

Ruby Jain has 3 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available